Quantres Asset Management LTD Lowered Regeneron Pharmaceuticals (REGN) Position; Nationstar Mortgage Holdings Inc. (NSM) Had 4 Bulls

Nationstar Mortgage Holdings Inc. (NYSE:NSM) Logo

Among 14 analysts covering Nationstar Mortgage Holdings (NYSE:NSM), 4 have Buy rating, 3 Sell and 7 Hold. Therefore 29% are positive. Nationstar Mortgage Holdings has $2200 highest and $14 lowest target. $18.30’s average target is 0.44% above currents $18.22 stock price. Nationstar Mortgage Holdings had 36 analyst reports since July 31, 2015 according to SRatingsIntel. Morgan Stanley downgraded the stock to “Underweight” rating in Wednesday, December 16 report. The stock has “Hold” rating by Keefe Bruyette & Woods on Tuesday, September 12. The company was upgraded on Friday, July 31 by FBR Capital. Credit Suisse maintained Nationstar Mortgage Holdings Inc. (NYSE:NSM) on Tuesday, February 20 with “Outperform” rating. As per Thursday, August 3, the company rating was maintained by Piper Jaffray. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Thursday, December 21 report. The stock of Nationstar Mortgage Holdings Inc. (NYSE:NSM) has “Hold” rating given on Monday, May 29 by Keefe Bruyette & Woods. The rating was maintained by FBR Capital on Friday, February 26 with “Mkt Perform”. The firm earned “Sell” rating on Sunday, September 17 by Piper Jaffray. The stock of Nationstar Mortgage Holdings Inc. (NYSE:NSM) earned “Neutral” rating by Piper Jaffray on Friday, September 9. See Nationstar Mortgage Holdings Inc. (NYSE:NSM) latest ratings:

05/03/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $20.0 Maintain
02/03/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $18 New Target: $19 Maintain
20/02/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $23 New Target: $20 Maintain
13/02/2018 Broker: Piper Jaffray Rating: Sell Downgrade
10/01/2018 Broker: Piper Jaffray Rating: Hold New Target: $18.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $22.0 Maintain
11/12/2017 Broker: Barclays Capital Rating: Sell New Target: $18.0
21/11/2017 Broker: PiperJaffray Old Rating: Underweight New Rating: Neutral Upgrade

Quantres Asset Management Ltd decreased Regeneron Pharmaceuticals (REGN) stake by 75.86% reported in 2017Q4 SEC filing. Quantres Asset Management Ltd sold 2,200 shares as Regeneron Pharmaceuticals (REGN)’s stock declined 13.59%. The Quantres Asset Management Ltd holds 700 shares with $263,000 value, down from 2,900 last quarter. Regeneron Pharmaceuticals now has $31.91 billion valuation. The stock decreased 1.69% or $5.08 during the last trading session, reaching $296.14. About 913,527 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 14.19% since May 3, 2017 and is downtrending. It has underperformed by 25.74% the S&P500.

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 12 have Buy rating, 1 Sell and 20 Hold. Therefore 36% are positive. Regeneron Pharmaceuticals Inc. has $700 highest and $300 lowest target. $486.96’s average target is 64.44% above currents $296.14 stock price. Regeneron Pharmaceuticals Inc. had 122 analyst reports since July 28, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Hold” rating in Thursday, August 3 report. The firm has “Hold” rating given on Monday, September 11 by BMO Capital Markets. The rating was upgraded by Zacks to “Hold” on Tuesday, August 11. The firm earned “Hold” rating on Thursday, February 8 by BMO Capital Markets. UBS upgraded the shares of REGN in report on Monday, September 7 to “Buy” rating. The rating was downgraded by Chardan Capital Markets on Wednesday, March 16 to “Sell”. Raymond James initiated Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday, September 1 with “Outperform” rating. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Buy” rating given on Friday, July 21 by Piper Jaffray. On Thursday, February 16 the stock rating was downgraded by Goldman Sachs to “Neutral”. The firm earned “Hold” rating on Wednesday, February 21 by Canaccord Genuity.

Since February 9, 2018, it had 0 insider buys, and 3 selling transactions for $1.71 million activity. On Wednesday, March 14 GOLDSTEIN JOSEPH L sold $680,000 worth of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) or 2,000 shares.

Quantres Asset Management Ltd increased Zimmer Biomet Holdings Inc (ZMH) stake by 10,400 shares to 12,300 valued at $1.48 million in 2017Q4. It also upped Ppl Corp (NYSE:PPL) stake by 20,500 shares and now owns 28,600 shares. Apache Corp (NYSE:APA) was raised too.

Investors sentiment is 1.17 in 2017 Q4. Its the same as in 2017Q3. It has no change, as 62 investors sold REGN shares while 161 reduced holdings. only 71 funds opened positions while 191 raised stakes. 69.17 million shares or 6.15% less from 73.70 million shares in 2017Q3 were reported. Whittier reported 58 shares or 0% of all its holdings. Lazard Asset Mgmt Lc reported 4 shares stake. Apg Asset Management Nv stated it has 0.01% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Mackenzie Fin holds 543 shares or 0% of its portfolio. Kelly Lawrence W & Assoc Ca invested in 25,265 shares or 1.75% of the stock. Jefferies Gp Limited Company owns 6,456 shares. American Grp Inc Inc Inc, New York-based fund reported 34,769 shares. Nomura Asset Mgmt Limited invested in 17,502 shares or 0.08% of the stock. State Treasurer State Of Michigan stated it has 0.07% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Genesee Valley Trust Co, a New York-based fund reported 4,076 shares. Us Bank De holds 6,164 shares or 0.01% of its portfolio. Citadel Lc invested 0.04% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Checchi Advisers Limited Liability reported 0.03% stake. Utah Retirement reported 0.12% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Reliance Tru Of Delaware has invested 0.09% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).

Nationstar Mortgage Holdings Inc. provides servicing, origination, and transaction based services primarily to single-family residences in the United States. The company has market cap of $1.79 billion. It operates in three divisions: Servicing, Originations, and Xome. It has a 60.73 P/E ratio. The Servicing segment offers conventional residential mortgage loans and home equity conversion loans.

The stock increased 0.33% or $0.06 during the last trading session, reaching $18.22. About 233,911 shares traded. Nationstar Mortgage Holdings Inc. (NYSE:NSM) has risen 19.73% since May 3, 2017 and is uptrending. It has outperformed by 8.18% the S&P500.

Investors sentiment increased to 1.46 in 2017 Q4. Its up 0.42, from 1.04 in 2017Q3. It improved, as 8 investors sold Nationstar Mortgage Holdings Inc. shares while 33 reduced holdings. 19 funds opened positions while 41 raised stakes. 94.30 million shares or 0.90% less from 95.15 million shares in 2017Q3 were reported. Alliancebernstein Lp holds 291,280 shares or 0% of its portfolio. Tiaa Cref Investment Lc has 241,140 shares. One Trading Ltd Partnership invested 0.01% in Nationstar Mortgage Holdings Inc. (NYSE:NSM). 52 were accumulated by Sei Com. Ameritas Invest Prtn stated it has 2,532 shares or 0% of all its holdings. Invesco Limited invested in 141,881 shares or 0% of the stock. Geode Capital Mgmt Limited Liability Corp accumulated 0% or 318,973 shares. Ubs Asset Management Americas accumulated 10,199 shares or 0% of the stock. Ing Groep Nv has 227,190 shares. Proxima Capital Limited Co accumulated 360,137 shares. Ardsley Advisory Partners owns 625,000 shares for 1.4% of their portfolio. Convergence Invest Limited Company holds 81,730 shares or 0.2% of its portfolio. The New York-based Fortress Inv Group Incorporated Lc has invested 32.71% in Nationstar Mortgage Holdings Inc. (NYSE:NSM). Hap Trading Limited Com owns 229,959 shares for 0.18% of their portfolio. New York State Teachers Retirement Sys accumulated 2,500 shares.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Institutional Positions Chart